Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 1,960 | 1,772 | 1,943 | 1,881 | 2,537 |
| Gross Profit | 1,960 | 1,772 | 1,943 | 1,881 | 2,537 |
| Operating Expenses | 15,413 | 15,323 | 14,482 | 14,745 | 12,637 |
| Operating Income | -13,453 | -13,551 | -12,539 | -12,864 | -10,100 |
| Interest Expense | 65 | 60 | 51 | 44 | 43 |
| Other Income | 964 | 1,211 | 1,327 | 1,041 | 625 |
| Pre-tax Income | -12,554 | -12,400 | -11,263 | -11,867 | -9,518 |
| Net Income Continuous | -12,554 | -12,400 | -11,263 | -11,867 | -9,518 |
| Net Income | $-12,554 | $-12,451 | $-11,263 | $-11,867 | $-9,467 |
| EPS Basic Total Ops | -0.42 | -0.41 | -0.38 | -0.43 | -0.39 |
| EPS Basic Continuous Ops | -0.42 | -0.41 | -0.38 | -0.43 | -0.39 |
| EPS Diluted Total Ops | -0.42 | -0.41 | -0.38 | -0.43 | -0.39 |
| EPS Diluted Continuous Ops | -0.42 | -0.41 | -0.38 | -0.43 | -0.39 |
| EBITDA(a) | $-13,048 | $-14,300 | $-12,320 | $-12,669 | $-9,911 |